Johnson & Johnson Begins Largest Late-Stage Trial To-Date for COVID-19 Vaccine
XTalks
AUGUST 27, 2020
With vaccine trials for COVID-19 ramping up and entering late stages, Johnson & Johnson has announced plans for what will be the largest Phase III trial so far for a vaccine against the novel coronavirus. This is double the enrollment that vaccine makers Moderna and Pfizer have planned for their Phase III trials.
Let's personalize your content